Holen Sie sich die Stockscreener-App
46.92
0.90%
0.42
Vorhandelsmarkt:
47.10
0.18
+0.38%
Schlusskurs vom Vortag:
$46.50
Offen:
$47.35
24-Stunden-Volumen:
2.31M
Relative Volume:
1.62
Marktkapitalisierung:
$10.08B
Einnahmen:
$1.98B
Nettoeinkommen (Verlust:
$83.59M
KGV:
125.45
EPS:
0.374
Netto-Cashflow:
$502.31M
1W Leistung:
-3.97%
1M Leistung:
-6.05%
6M Leistung:
+22.19%
1J Leistung:
-0.20%
1-Tages-Spanne:
$46.62
$47.38
1-Wochen-Bereich:
$45.81
$48.73
52-Wochen-Spanne:
$37.74
$51.88
Qiagen Nv Stock (QGEN) Company Profile
Firmenname
Qiagen Nv
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie QGEN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
QGEN
Qiagen Nv
|
46.92 | 10.08B | 1.98B | 83.59M | 502.31M | 0.374 |
|
TMO
Thermo Fisher Scientific Inc
|
487.53 | 186.06B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
203.79 | 147.38B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
639.45 | 51.77B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
125.21 | 35.62B | 6.79B | 1.22B | 1.09B | 4.26 |
|
IQV
Iqvia Holdings Inc
|
183.74 | 32.44B | 15.70B | 1.24B | 2.01B | 6.91 |
Qiagen Nv Stock (QGEN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-24 | Eingeleitet | Barclays | Overweight |
| 2025-04-04 | Herabstufung | Redburn Atlantic | Buy → Neutral |
| 2025-02-19 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2025-01-06 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2024-12-10 | Hochstufung | Jefferies | Hold → Buy |
| 2024-10-17 | Herabstufung | HSBC Securities | Buy → Hold |
| 2024-06-27 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2023-12-19 | Eingeleitet | Wells Fargo | Equal Weight |
| 2023-12-13 | Eingeleitet | Wolfe Research | Peer Perform |
| 2023-12-07 | Hochstufung | Goldman | Neutral → Buy |
| 2023-09-12 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-05-23 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-10-18 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2022-01-18 | Hochstufung | DZ Bank | Hold → Buy |
| 2021-10-15 | Fortgesetzt | Cowen | Market Perform |
| 2021-10-14 | Eingeleitet | Redburn | Buy |
| 2021-07-14 | Herabstufung | Kepler | Buy → Hold |
| 2021-06-03 | Eingeleitet | Goldman | Neutral |
| 2020-10-06 | Fortgesetzt | BofA Securities | Buy |
| 2020-09-28 | Hochstufung | Kepler | Hold → Buy |
| 2020-08-24 | Hochstufung | Citigroup | Neutral → Buy |
| 2020-08-20 | Fortgesetzt | JP Morgan | Overweight |
| 2020-08-17 | Hochstufung | Berenberg | Hold → Buy |
| 2020-08-14 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2020-08-14 | Hochstufung | Exane BNP Paribas | Neutral → Outperform |
| 2020-03-04 | Herabstufung | Berenberg | Buy → Hold |
| 2020-01-08 | Eingeleitet | Wells Fargo | Equal Weight |
| 2020-01-07 | Eingeleitet | Citigroup | Neutral |
| 2019-12-26 | Fortgesetzt | BofA/Merrill | Underperform |
| 2019-11-15 | Eingeleitet | Stifel | Hold |
| 2019-11-14 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2019-11-14 | Hochstufung | JP Morgan | Underweight → Overweight |
| 2019-11-14 | Hochstufung | Kepler | Reduce → Hold |
| 2019-10-17 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2019-10-09 | Herabstufung | Kepler | Hold → Reduce |
| 2019-10-08 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2019-10-08 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2019-10-08 | Herabstufung | JP Morgan | Neutral → Underweight |
Alle ansehen
Qiagen Nv Aktie (QGEN) Neueste Nachrichten
When is the best time to exit Qiagen N.V.2025 Market WrapUp & Expert Approved Trade Ideas - Newser
Analyzing recovery setups for Qiagen N.V. investors2025 Earnings Impact & Weekly Market Pulse Updates - Newser
Earnings visualization tools for Qiagen N.V.Market Activity Recap & AI Optimized Trade Strategies - Newser
Qiagen N.V. stock prediction for this weekEarnings Overview Report & Low Risk High Win Rate Picks - Newser
Chart based analysis of Qiagen N.V. trendsJuly 2025 Short Interest & Proven Capital Preservation Methods - Newser
What’s next for Qiagen N.V. stockJuly 2025 Analyst Calls & Safe Capital Growth Stock Tips - خودرو بانک
Can Qiagen N.V. expand into new marketsJuly 2025 Fed Impact & Verified Stock Trade Ideas - خودرو بانک
QIAGEN Gains U.S. Clearance of Higher-Throughput QIAstat-Dx Rise, Expanding Patient Access to Rapid Syndromic Testing - sharewise.com
Qiagen N.V.’s volatility index tracking explainedWeekly Trend Recap & Smart Money Movement Tracker - Newser
Qiagen’s Voting Rights Announcement Involves BlackRock’s Significant Holdings - MSN
Qiagen's (NYSE:QGEN) Strong Earnings Are Of Good Quality - simplywall.st
Hemato-Oncology Testing Market Size, Share & Trends Analysis Report 2025-2030 Featuring Key Players Roche, Abbott, EntroGen, Qiagen, and Cepheid (Danaher) Among Others - uk.finance.yahoo.com
Qiagen shares rise 1.53% premarket after FDA clearance of higher-throughput QIAstat-Dx Rise system. - AInvest
Is Qiagen N.V. forming a bullish divergenceM&A Rumor & Smart Allocation Stock Reports - خودرو بانک
QIAGEN N.V. Launches QIAstat-Dx Rise, a High-Throughput Automated Syndromic Testing System with FDA Clearance. - AInvest
How does Qiagen N.V. score in quality rankings2025 Top Decliners & Long-Term Safe Return Strategies - خودرو بانک
How to escape a deep drawdown in Qiagen N.V.July 2025 Earnings & Risk Adjusted Buy and Sell Alerts - Newser
QIAGEN receives FDA clearance for higher-throughput diagnostic system - StreetInsider
Qiagen Says US FDA Clears Syndromic Testing System - 富途牛牛
US FDA Clears Qiagen's Syndromic Testing System - AInvest
Qiagen Gains US Clearance for Higher-Throughput QIAstat-Dx Rise - AInvest
QIAGEN Introduces QIAstat-Dx Rise: A Higher-Throughput Automated Syndromic Testing System Cleared by FDA. - AInvest
Qiagen gains U.S. clearance of higher-throughput QIAstat-Dx Rise - MarketScreener
160 Tests Per Day: QIAGEN's New QIAstat-Dx Rise System Receives FDA Clearance for Rapid Diagnostics - Stock Titan
Is Qiagen N.V. currently under institutional pressureWeekly Profit Analysis & Technical Entry and Exit Alerts - خودرو بانک
Does Qiagen N.V. have a sustainable dividend2025 Trading Volume Trends & AI Driven Price Predictions - خودرو بانک
Real time pattern detection on Qiagen N.V. stockJuly 2025 Sentiment & Verified Momentum Watchlists - Newser
Qiagen grabbed 'opportunistic window' to sell $750m CB - GlobalCapital
Can Qiagen N.V. be the next market leaderJuly 2025 Update & Daily Growth Stock Tips - خودرو بانک
Does Qiagen N.V. meet Warren Buffett’s criteriaJuly 2025 Summary & Risk Managed Trade Strategies - خودرو بانک
Sentiment analysis tools applied to Qiagen N.V.2025 Year in Review & Verified Chart Pattern Signals - Newser
Trend Dashboard Flags Qiagen N.V. As Potential Swing Trade getLinesFromResByArray error: size == 0 - kangso.co.kr
Multi asset correlation models including Qiagen N.V.Market Performance Summary & Risk Controlled Swing Alerts - Newser
Can swing trading help recover from Qiagen N.V. lossesWeekly Volume Report & Growth Focused Investment Plans - Newser
What Fibonacci levels say about Qiagen N.V. reboundSell Signal & Free Weekly Chart Analysis and Trade Guides - Newser
Qiagen N.V. stock trend forecastWeekly Trend Summary & Safe Capital Investment Plans - Newser
Will Qiagen N.V. stock go up soonTrade Volume Report & Free Weekly Chart Analysis and Trade Guides - Newser
Does Qiagen N.V. qualify in momentum factor screeningBond Market & Long-Term Safe Investment Plans - Newser
What is the next catalyst for Qiagen N.V.Weekly Investment Recap & Risk Managed Investment Strategies - sundaytimes.kr
Finanzdaten der Qiagen Nv-Aktie (QGEN)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.76%
0.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):